This first evidence confirms the inability of breast cancer cells to control the interphase check points (even after serum deprivation), and enabled to set the nutrient conditions for the next experimental approach, where the presence of Ki-67 has been further quantified as a function of the interphase sub-phases. The gene discussed is MKI67; the disease is breast carcinoma.